Background
Tetanus toxin (TeNT) is an exotoxin produced by Clostridium tetani that invades the body through damaged skin epidermis or mucous membranes, causing Clostridium tetani to multiply in large numbers in an oxygen-deficient environment. Tetanus is a specific infectious disease that can cause local or systemic acute muscle spasms. The disease can infect humans or animals but is not contagious. Clostridium tetani is a Gram-positive anaerobic bacillus. It is the pathogen that causes tetanus and is mainly found in soil or feces. Clostridium tetani itself does not have the ability to invade and harm the human body. It cannot invade normal skin tissue and mucous membranes. It can only grow and multiply in local wound tissue, thereby producing clostridial neurotoxins.
Figure 1. The five steps of the molecular mechanism underlying the neuroparalytic action of tetanus neurotoxin (TeNT) and botulinum neurotoxins (BoNTs). (Sources: Pirazzini M, et al. 2022)
TeNT is a protein neurotoxin, which is the second most virulent biological toxin after botulinum toxin. About 100 ng can kill a person. The mortality rate of patients poisoned by tetanus toxin is very high. Even with active treatment, the mortality rate of tetanus patients is still as high as 20%~40%. TeNT is a neurotoxin produced by Clostridium tetani. It is composed of 1315 amino acids and is a protein with a relative molecular mass of 150kDa. Its structure is similar to that of botulinum toxin. Naturally formed TeNT is initially non-toxic and exists in the form of a single-chain polypeptide. Mature TeNT is toxic only when it is cleaved by bacterial proteases or in vitro proteases to form a double-chain form. The double-chain form of TeNT is composed of a light chain (Light chain, L) and a heavy chain (Heavy chain, H) connected by a pair of disulfide bonds. Among them, H is composed of two domains, namely the amino terminus of the heavy chain (N-terminal of Heavy chain, Hn) and the carboxyl terminus of the heavy chain (C-terminal of Heavy chain, Hc). L is the active part of the toxin, which has Zn2+-dependent endonuclease activity and has the function of cutting the substrate VAMP-2 protein; H can make the protein break through the blood-brain barrier and enter the central nervous system. Hc is a domain of about 50kDa composed of 4 a helices and 6 beta folds, which is also a ganglioside domain. This domain contains two polysialic acid ganglioside binding sites, which is responsible for recognizing and binding to receptors on the outer plasma membrane of motor neurons; Hn is a migration domain, which is composed of two a helices and has a relative molecular mass of about 50kDa. It is responsible for delivering the toxin light chain to the inside of the neuronal cell, so that the active part of the toxin interacts with the SNARE protein complex, inhibiting the continuous release of acetylcholine, and the motor neurons will be in a state of continuous excitement, which will eventually lead to continuous muscle contraction and tetanic contraction, which can cause death in severe cases.
In nature, tetanus toxin first exists in the form of a non-toxic precursor toxin. It needs to further mature and form a double-chain structure to be toxic, connected by disulfide bonds. Although tetanus toxin and botulinum toxin are equally deadly, their poisoning reactions and poisoning mechanisms are completely different. The heavy chain of botulinum toxin can bind to receptors on the surface of nerve cells, and the toxin protein enters the cell through receptor-mediated endocytosis. After the toxin protein enters the cell, the light and heavy chains can be separated. The heavy chain can mediate the formation of transmembrane holes on the inner membrane, allowing the active part of the toxin to enter the cytoplasm; the light chain contains a Zn2+-dependent specific proteolytic enzyme region, which can cut related proteins and prevent the release of acetylcholine, ultimately leading to severe neurological disorders and flaccid paralysis. The transport of tetanus toxin in the body is neurotropic. TeNT protein binds to peripheral motor neurons through receptors and enters cells through receptor-mediated endocytosis, so that vesicles carrying toxin proteins can be transported in reverse, along peripheral nerve cells to the spinal cord, and then released from the junction of motor neurons and inhibitory neurons. The toxin protein enters the vesicles of inhibitory neurons, and then the vesicles become acidified, causing the disulfide bonds to dissociate. The light and heavy chain molecules enter the cytoplasm. The light chain molecules contain Zn2+-dependent specific protease regions that can cut VAMP-2 proteins, thereby inhibiting the release of neurotransmitters such as aminoacetic acid and aminobutyric acid. Since the target cells are inhibitory neurons, the lack of neurotransmitters leads to the disappearance of the inhibitory effect on motor neurons, causing motor neurons to remain in an excited state, which is clinically manifested as muscle tonic contraction.
Alternative Names
Tetanospasmin
TeNT
Clostridium tetani toxin
Tetanus neurotoxin
References
- 1. Pirazzini M, et al. Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update. Arch Toxicol. 2022, 96(6):1521-1539.
References
Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production
Pharmaceuticals (Basel)
Authors: Bayart C, Mularoni A, Hemmani N, Kerachni S, Jose J, Gouet P, Paladino J, Le Borgne M
Abstract
Tetanus toxoid (TTd) plays an important role in the pharmaceutical world, especially in vaccines. The toxoid is obtained after formaldehyde treatment of the tetanus toxin. In parallel, current emphasis in the drug discovery field is put on producing well-defined and safer drugs, explaining the interest in finding new alternative proteins. The tetanus toxin fragment C (TTFC) has been extensively studied both as a neuroprotective agent for central nervous system disorders owing to its neuronal properties and as a carrier protein in vaccines. Indeed, it is derived from a part of the tetanus toxin and, as such, retains its immunogenic properties without being toxic. Moreover, this fragment has been well characterized, and its entire structure is known. Here, we propose a systematic review of TTFC by providing information about its structural features, its properties and its methods of production. We also describe the large uses of TTFC in the field of drug discovery. TTFC can therefore be considered as an attractive alternative to TTd and remarkably offers a wide range of uses, including as a carrier, delivery vector, conjugate, booster, inducer, and neuroprotector.
Toxin-associated infectious diseases: tetanus, botulism and diphtheria
Curr Opin Neurol.
Authors: Pfausler B, Rass V, Helbok R, Beer R
Abstract
Purpose of review: The incidence rates of the toxin-related infectious diseases, tetanus, diphtheria and botulism declined dramatically over the past decades mainly because of the implementation of immunization programs also in low-and-middle-income countries (LAMICs) and by improving hygiene conditions. But still, single cases occur, and they need fastest possible recognition and management.
Recent findings: Over the past 20 years, the incidence of neonatal tetanus has declined by more than 90%. This success was achieved by immunizing women in reproductive age in areas of high risk as sub-Saharan Africa and parts of Asia. Larger regional outbreaks of diphtheria have been reported from the former Soviet Union in the 1990s and from India in 2017. Botulism is still rare, mainly seen in infants and, in recent years, in intravenous drug abusers.
Summary: Tetanus, diphtheria and botulism are rarities in high-income countries (HICs) with unlimited access to immunization programs and standard hygiene procedures. The diagnosis of all three diseases is still, even in the 21st century, based upon patient's history and clinical signs and symptoms. Neither biochemical bedside tests nor neuroradiological investigations help to confirm the diagnosis in an emergency situation.
Tetanus and tetanus neurotoxin: From peripheral uptake to central nervous tissue targets
J Neurochem
Authors: Megighian A, Pirazzini M, Fabris F, Rossetto O, Montecucco C
Abstract
Tetanus is a deadly but preventable disease caused by a protein neurotoxin produced by Clostridium tetani. Spores of C. tetani may contaminate a necrotic wound and germinate into a vegetative bacterium that releases a toxin, termed tetanus neurotoxin (TeNT). TeNT enters the general circulation, binds to peripheral motor neurons and sensory neurons, and is transported retroaxonally to the spinal cord. It then enters inhibitory interneurons and blocks the release of glycine or GABA causing a spastic paralysis. This review attempts to correlate the metalloprotease activity of TeNT and its trafficking and localization into the vertebrate body to the nature and sequence of appearance of the symptoms of tetanus.